FDA pressed to rescind approval of Zohydro painkiller

FDA pressed to rescind approval of Zohydro painkiller

An Allegheny Health Network physician has joined the outcry over U.S. Food and Drug Administration approval of a potent new opioid painkiller, which shows potential for abuse, diversion for illegal use and accidental overdose. The extended-release 

5
Like
Save

Comments

Write a comment

*